Clinical Trial Update: Henagliflozin's Impact on Prediabetes Remission [Phase 4]

View source ↗

Summary

Phase 4 trial updating on Henagliflozin for remission of prediabetes; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorders of Glucose Metabolism
• Prediabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• Henagliflozin (henagliflozin)

Snippet

Sponsor: Shandong Provincial Hospital | Conditions: PreDiabetes, Prediabetic State | Phase 4 | Status: NOT_YET_RECRUITING